Atlas Trials

Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

Clinical trial NCT06830421 · RECRUITING

Trial details

NCT number
NCT06830421
Sponsor
University Hospital Freiburg
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Primary Central Nervous System Lymphoma
Start date
2023-08-09
Primary completion
2029-08-31
Enrollment
340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.